1. Potential inhibitors of L-asparagine biosynthesis. 4. Substituted sulfonamide and sulfonylhydrazide analogues of L-asparagine.
- Author
-
Brynes S, Burckart GJ, and Mokotoff M
- Subjects
- Animals, Asparagine chemical synthesis, Asparagine pharmacology, Asparagine therapeutic use, Carcinoma, Hepatocellular enzymology, Hydrazines chemical synthesis, Hydrazines pharmacology, Hydrazines therapeutic use, In Vitro Techniques, Leukemia, Experimental drug therapy, Liver Neoplasms enzymology, Mice, Neoplasms, Experimental enzymology, Rats, Structure-Activity Relationship, Sulfonamides chemical synthesis, Sulfonamides pharmacology, Sulfonamides therapeutic use, Asparagine analogs & derivatives, Aspartate-Ammonia Ligase antagonists & inhibitors, Ligases antagonists & inhibitors
- Abstract
Several N-substituted sulfonamides and N'-substituted sulfonylhydrazides have been prepared as sulfur analogues of L-asparagine with the potential of acting as inhibitors of L-asparagine synthetase (ASase, from Novikoff hepatoma). L-Cysteine was converted in known steps to N-carboxy-3-(sulfonylchloro)-L-alanine dibenzyl ester (1). Condensation of 1 with O-benzylhydroxylamine, p-(fluorosulfonyl)benzylamine, or monoethyl fumarylhydrazide (9), followed by deblocking with HF, gave 3-(hydroxysulfamoyl)-L-alanine (3a), 3-[p-(fluorosulfonylbenzyl)]sulfamoyl-L-alanine (3c), and 3-sulfo-L-alanine S-[2-[(E)-3-(ethoxycarbonyl)acryloyl]hydrazide] (3e), respectively. Similarly, 1 with 2-chloroethylamine and deblocking with H2-Pd gave 3-[(2-chloroethyl)sulfamoyl]-L-alanine (3b). tert-Butyl carbazate was allowed to react with 1 and the tert-butyl group was removed with HCl. The resulting sulfonylhydrazide 7 was condensed with p-(fluorosulfonyl)benzoyl chloride and then deblocked with HF to give 3-sulfo-L-alanine S-[2-[P-(fluorosulfonyl)benzoyl]hydrazide] (3d). The inhibition of ASase by 3a-e at 2 mM was 97, 0, 30, 43, and 37%, respectively, and 3a was competitive with L-aspartic acid. Neither 3a nor 3e was effective in increasing the life span of mice bearing P-388 lymphocytic leukemia.
- Published
- 1978
- Full Text
- View/download PDF